Furja(SH:603219)2022-10-26 16:00Financial Performance - The company's operating revenue for Q3 2022 was ¥762,947,489.50, representing a year-on-year increase of 7.05%[7] - The net profit attributable to shareholders for Q3 2022 was ¥124,101,639.69, an increase of 32.57% compared to the same period last year[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2022 was ¥123,293,197.05, showing a significant increase of 101.67% year-on-year[7] - The basic earnings per share for Q3 2022 was ¥0.31, reflecting a year-on-year increase of 19.23%[10] - The net profit for the third quarter of 2022 was approximately CNY 274.53 million, an increase from CNY 198.29 million in the same period of 2021, representing a growth of 38.4%[41] - The total comprehensive income attributable to the parent company for the third quarter was CNY 272.25 million, compared to CNY 197.52 million in the previous year, reflecting a year-over-year increase of 37.8%[42] - The basic and diluted earnings per share for the third quarter were both CNY 0.68, up from CNY 0.55 in the same quarter of 2021, indicating a 23.6% increase[42] Assets and Liabilities - The total assets at the end of Q3 2022 were ¥2,301,791,326.97, a decrease of 5.75% compared to the end of the previous year[10] - The total assets decreased from ¥2,442,238,879.40 to ¥2,301,791,326.97, a decline of about 5.8%[34] - Total liabilities decreased from ¥1,136,282,359.99 to ¥882,058,618.13, representing a reduction of approximately 22.4%[34] - The total equity attributable to shareholders at the end of Q3 2022 was ¥1,412,710,111.65, an increase of 8.60% compared to the same period last year[10] - The equity attributable to shareholders increased from ¥1,300,860,275.12 to ¥1,412,710,111.65, showing an increase of about 8.6%[34] Cash Flow - The company reported a net cash flow from operating activities of ¥457,120,290.38 for the year-to-date period[10] - Cash flow from operating activities for the third quarter was CNY 457.12 million, a significant recovery from a negative cash flow of CNY 130.46 million in the same quarter of the previous year[45] - The company reported cash inflows from operating activities totaling CNY 2.33 billion, compared to CNY 1.91 billion in the same period last year, marking an increase of 22.4%[45] - The total cash outflow from operating activities was CNY 1.88 billion, down from CNY 2.04 billion in the previous year, showing a decrease of 8.1%[45] - The net cash flow from investing activities was negative CNY 184.54 million, compared to a positive CNY 9.81 million in the same quarter of 2021, indicating a decline in investment returns[46] - The net cash flow from financing activities was negative CNY 211.90 million, worsening from a negative CNY 103.41 million in the same period last year[46] - The cash and cash equivalents at the end of the period stood at CNY 444.96 million, a significant increase from CNY 49.80 million at the end of the same quarter in 2021[46] - The company received CNY 319.09 million in cash from borrowings during the third quarter, compared to CNY 245.51 million in the same period last year, reflecting a 29.9% increase in financing activities[46] Investments and Strategic Initiatives - The company completed a share transfer agreement with Beijing Haishi Ruige Technology Co., Ltd., enhancing its strategic investments[24] - The company holds a 65% stake in Zhejiang Lanbei Medical Technology Co., Ltd., with an investment amount of RMB 6,500,000[26] - The company aims to create greater shareholder value through strategic investments and long-term development plans[26] - The company has no significant adverse impact on its financial and operational status from recent investments[26] Shareholder Information - The top ten shareholders hold a combined 82.92% of the shares, indicating concentrated ownership[22] Operating Costs and Expenses - Total operating revenue for the first three quarters of 2022 reached ¥1,994,694,694.34, an increase from ¥1,902,029,905.64 in the same period of 2021, representing a growth of approximately 4.8%[36] - Total operating costs for the first three quarters of 2022 were ¥1,681,815,039.64, down from ¥1,719,966,025.58 in the previous year, indicating a decrease of about 2.2%[36] - Research and development expenses increased to ¥66,005,381.87 in 2022 from ¥54,163,055.54 in 2021, reflecting a growth of approximately 21.9%[36] Foreign Exchange and Non-Recurring Gains - The company experienced an increase in foreign exchange gains contributing to the rise in net profit for both the current quarter and year-to-date[16] - Non-recurring gains for Q3 2022 included government subsidies amounting to ¥697,208.59, primarily from local government awards[11] Current Assets Management - As of September 30, 2022, the total current assets amounted to RMB 1,138,000,000, an increase from RMB 1,052,000,000 as of December 31, 2021[27] - Cash and cash equivalents were RMB 483,074,930.69, up from RMB 432,270,971.28 in the previous year[27] - The company reported a significant increase in trading financial assets, rising to RMB 206,080,770.62 from RMB 70,011,592.26[27] - Accounts receivable decreased to RMB 572,422,540.89 from RMB 693,824,478.22, indicating improved collection efficiency[27] - Inventory levels decreased to RMB 366,304,994.13 from RMB 479,471,299.78, reflecting better inventory management[27] Return on Equity - The weighted average return on equity for Q3 2022 was 8.95%, down by 1.54 percentage points year-on-year[10]